Nombre del producto:5-cyclopropyl-1,3,4-thiadiazol-2-amine

IUPAC Name:5-cyclopropyl-1,3,4-thiadiazol-2-amine

CAS:57235-50-4
Fórmula molecular:C5H7N3S
Pureza:95%+
Número de catálogo:CM113601
Peso molecular:141.19

Unidad de embalaje Stock disponible Precio($) Cantidad
CM113601-5g in stock ŪƥŞ
CM113601-25g in stock ƥƿȯ

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :57235-50-4
Fórmula molecular:C5H7N3S
Punto de fusión:-
Código de sonrisas:NC1=NN=C(C2CC2)S1
Densidad:
Número de catálogo:CM113601
Peso molecular:141.19
Punto de ebullición:310.8°C at 760 mmHg
Nº Mdl:MFCD00051649
Almacenamiento:Keep in dark place, store at 2-8°C.

Category Infos

Cyclopropanes
Cyclopropane is the smallest cyclic compound with unique structural features and physicochemical properties, which is widely used in the design of small molecule drugs. In drug design, it is often used to increase activity, fix conformation and improve PK and water solubility. The introduction of cyclopropyl groups into drugs can change various properties of molecules, such as improving metabolic stability; increasing biological activity; enhancing drug efficacy; limiting polypeptide conformation and slowing down its hydrolysis; reducing plasma clearance; improving drug dissociation and many more. Cyclopropane rings are widely found in marketed drugs, including cardiovascular drugs, central nervous system (CNS) drugs, anticancer drugs, autoimmune and anti-inflammatory drugs.
Thiadiazoles
Thiadiazoles are a subfamily of azoles. Structurally, they are five-membered heterocyclic compounds containing two nitrogen atoms and one sulfur atom, and two double bonds, forming an aromatic ring. Depending on the relative positions of the heteroatoms, there are four possible structures; these forms do not interconvert and are therefore structural isomers rather than tautomers. These compounds themselves are rarely synthesized and have no particular utility, however, compounds that use them as structural motifs are fairly common in pharmacology.